Drug record
What four public record sets show for methylphenidate. Saved Nov 10, 2026.
| Shortage | On the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.122 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $54.9 million | Details |
| FDA recall records | 66 | Details |
Whether the FDA lists this drug as in short supply.
Reason given: Discontinuation of the manufacture of the drug
Reason given: Discontinuation of the manufacture of the drug
Reason given: Other
Reason given: Demand increase for the drug
Reason given: Other
Reason given: Discontinuation of the manufacture of the drug
Reason given: Demand increase for the drug
Reason given: Demand increase for the drug
Reason given: Other
Reason given: Demand increase for the drug
Reason given: Discontinuation of the manufacture of the drug
Reason given: Demand increase for the drug
Reason given: Other
Showing 30 of 38. See all of them live.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Methylphenidate 5 Mg Tablet: pharmacies pay about $0.122 each, or $3.65 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| METHYLPHENIDATE 10 MG CHEW TAB | Generic | $2.90 per each | $86.93 | Oct 21, 2026 |
| METHYLPHENIDATE 10 MG TABLET | Generic | $0.150 per each | $4.49 | Oct 21, 2026 |
| METHYLPHENIDATE 10 MG/5 ML SOL | Generic | $0.116 per mL | — | Oct 21, 2026 |
| METHYLPHENIDATE 10 MG/9 HR PATCH | Generic | $6.30 per each | $188.92 | Oct 21, 2026 |
| METHYLPHENIDATE 15 MG/9 HR PATCH | Generic | $6.27 per each | $188.14 | Oct 21, 2026 |
| METHYLPHENIDATE 2.5 MG CHEW TB | Generic | $1.31 per each | $39.37 | Oct 21, 2026 |
| METHYLPHENIDATE 20 MG TABLET | Generic | $0.199 per each | $5.98 | Oct 21, 2026 |
| METHYLPHENIDATE 20 MG/9 HR PATCH | Generic | $6.16 per each | $184.70 | Oct 21, 2026 |
| METHYLPHENIDATE 30 MG/9 HR PATCH | Generic | $6.61 per each | $198.34 | Oct 21, 2026 |
| METHYLPHENIDATE 5 MG CHEW TAB | Generic | $1.99 per each | $59.68 | Oct 21, 2026 |
| METHYLPHENIDATE 5 MG TABLET | Generic | $0.122 per each | $3.65 | Oct 21, 2026 |
| METHYLPHENIDATE 5 MG/5 ML SOLN | Generic | $0.079 per mL | — | Oct 21, 2026 |
| METHYLPHENIDATE CD 10 MG CAP | Generic | $1.52 per each | $45.71 | Oct 21, 2026 |
| METHYLPHENIDATE CD 20 MG CAP | Generic | $1.46 per each | $43.76 | Oct 21, 2026 |
| METHYLPHENIDATE CD 30 MG CAP | Generic | $1.81 per each | $54.20 | Oct 21, 2026 |
| METHYLPHENIDATE CD 40 MG CAP | Generic | $1.62 per each | $48.57 | Oct 21, 2026 |
| METHYLPHENIDATE CD 50 MG CAP | Generic | $1.73 per each | $52.03 | Oct 21, 2026 |
| METHYLPHENIDATE CD 60 MG CAP | Generic | $1.89 per each | $56.61 | Oct 21, 2026 |
| METHYLPHENIDATE ER 10 MG TAB | Generic | $0.455 per each | $13.65 | Oct 21, 2026 |
| METHYLPHENIDATE ER 18 MG TAB | Generic | $0.610 per each | $18.29 | Oct 21, 2026 |
| METHYLPHENIDATE ER 20 MG TAB | Generic | $0.510 per each | $15.31 | Oct 21, 2026 |
| METHYLPHENIDATE ER 27 MG TAB | Generic | $0.719 per each | $21.56 | Oct 21, 2026 |
| METHYLPHENIDATE ER 36 MG TAB | Generic | $0.689 per each | $20.68 | Oct 21, 2026 |
| METHYLPHENIDATE ER 45 MG TAB | Generic | $17.47 per each | $524.04 | Oct 21, 2026 |
| METHYLPHENIDATE ER 54 MG TAB | Generic | $0.822 per each | $24.66 | Oct 21, 2026 |
| METHYLPHENIDATE ER 63 MG TAB | Generic | $19.00 per each | $570.00 | Oct 21, 2026 |
| METHYLPHENIDATE ER 72 MG TAB | Generic | $16.09 per each | $482.67 | Oct 21, 2026 |
| METHYLPHENIDATE ER(CD) 10 MG CP | Generic | $1.52 per each | $45.71 | Oct 21, 2026 |
| METHYLPHENIDATE ER(CD) 20 MG CP | Generic | $1.46 per each | $43.76 | Oct 21, 2026 |
| METHYLPHENIDATE ER(CD) 30 MG CP | Generic | $1.81 per each | $54.20 | Oct 21, 2026 |
| METHYLPHENIDATE ER(CD) 40 MG CP | Generic | $1.62 per each | $48.57 | Oct 21, 2026 |
| METHYLPHENIDATE ER(CD) 50 MG CP | Generic | $1.73 per each | $52.03 | Oct 21, 2026 |
| METHYLPHENIDATE ER(CD) 60 MG CP | Generic | $1.89 per each | $56.61 | Oct 21, 2026 |
| METHYLPHENIDATE ER(LA) 10 MG CP | Generic | $2.35 per each | $70.36 | Oct 21, 2026 |
| METHYLPHENIDATE ER(LA) 20 MG CP | Generic | $1.62 per each | $48.48 | Oct 21, 2026 |
| METHYLPHENIDATE ER(LA) 30 MG CP | Generic | $1.72 per each | $51.56 | Oct 21, 2026 |
| METHYLPHENIDATE ER(LA) 40 MG CP | Generic | $1.77 per each | $53.05 | Oct 21, 2026 |
| METHYLPHENIDATE ER(LA) 60 MG CP | Generic | $10.03 per each | $300.97 | Oct 21, 2026 |
| CONCERTA ER 18 MG TABLET | Brand | $12.33 per each | $369.80 | Oct 21, 2026 |
| CONCERTA ER 27 MG TABLET | Brand | $12.65 per each | $379.46 | Oct 21, 2026 |
Showing 40 of 54 products on file.
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $54.9 million for the 17 products below. That is down 15% from $64.3 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Methylphenidate ER Methylphenidate HCl | $19.8 million | 37,138 | $87.69 | $533.57 | $27.1 million |
| Methylphenidate HCl Methylphenidate HCl | $15.1 million | 103,982 | $24.66 | $145.33 | $22.2 million |
| Concerta Methylphenidate HCl | $10.5 million | 3,972 | $545.69 | $2,653.84 | $5.0 million |
| Methylphenidate ER (La) Methylphenidate HCl | $3.3 million | 5,517 | $129.15 | $598.07 | $4.2 million |
| Jornay PM Methylphenidate HCl | $1.4 million | 543 | $474.30 | $2,588.99 | $147,850 |
| Methylphenidate HCl ER (Cd) Methylphenidate HCl | $1.3 million | 3,228 | $85.79 | $410.27 | $1.1 million |
| Ritalin Methylphenidate HCl | $720,435 | 1,179 | $127.47 | $611.06 | $950,661 |
| Methylphenidate HCl CD Methylphenidate HCl | $710,123 | 2,143 | $88.35 | $331.37 | $1.3 million |
| Ritalin La Methylphenidate HCl | $693,121 | 295 | $576.64 | $2,349.56 | $1.2 million |
| Methylphenidate Methylphenidate | $355,224 | 266 | $323.52 | $1,335.43 | — |
| Quillichew ER Methylphenidate HCl | $285,029 | 110 | $442.59 | $2,591.17 | $135,704 |
| Cotempla XR-ODT Methylphenidate | $191,560 | 41 | $804.88 | $4,672.20 | $93,132 |
| Quillivant XR Methylphenidate HCl | $188,309 | 58 | $611.39 | $3,246.71 | $116,921 |
| Daytrana Methylphenidate | $143,903 | 158 | $204.70 | $910.78 | $659,391 |
| Aptensio XR Methylphenidate HCl | $48,102 | 43 | $261.42 | $1,118.65 | $176,304 |
| Relexxii Methylphenidate HCl | $39,088 | 26 | $507.64 | $1,503.38 | — |
| Methylin Methylphenidate HCl | $2,773 | — | $89.46 | — | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 66 recall records that name methylphenidate in the product description (53 Class II · 13 Class III). 10 are still marked ongoing.
Methylphenidate Hydrochloride, Extended-release Tablets, USP, 36mg, 100-count Bottle, Rx Only, Manufactured for: Trigen Laboratories, LLC, Alpharetta, GA 30005, NDC 13811-708-10
Reason: Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
Methylphenidate Hydrochloride Tablets, USP 20mg, Rx Only, 100 Tablets per bottle, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, NDC 57664-230-88.
Reason: Presence of Foreign Substance: Metal embedded in a tablet.
Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5555-3
Reason: Defective Delivery System: Out of specification for shear.
Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.
Reason: Defective Delivery System: Out of specification for shear.
Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3
Reason: Defective Delivery System: Out of specification for shear.
Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5554-3.
Reason: Defective Delivery System: Out of specification for shear.
Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.
Reason: Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC 68968-5552-3
Reason: Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3
Reason: Defective Delivery System: customer complaints exceeded respective action limits.
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Reason: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.
Reason: Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.
Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1.6 mg/hr), 30 Patches (NDC 68968-5553-1) per box (NDC 68968-5553-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.
Reason: Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for methylphenidate. This page is public-record information, not medical advice.